Results of an open label study of zerit, videx, crixivan and norvir in protease inhibitor naive HIV-infected patients

被引：0
|
作者：
Anderson, R [1 ]
Williamson, D [1 ]
Corey, N [1 ]
Shultz, E [1 ]
Lenzi, D [1 ]
机构：
[1] Anderson Clin Res, Pittsburgh, PA USA
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P78
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [1] Boosted protease inhibitor monotherapy in HIV-infected patients: results of a study in a real life setting
    Di Benedetto, Nicolas
    Montero-Alonso, Marta
    Blanes, Marino
    Lacruz, Jose
    Cuellar, Sandra
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 (05) : 235 - 241
  • [2] Darunavir: an effective protease inhibitor for HIV-infected patients
    Phung, Bao-Chau
    Yeni, Patrick
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (06) : 631 - 643
  • [3] Lipoatrophy, fat accumulation, and mixed syndrome in protease inhibitor-naive HIV-infected patients
    Polo, R
    Verdejo, J
    Martinez-Rodriguez, S
    Madrigal, P
    Gonzalez-Muñoz, M
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) : 284 - 286
  • [4] A Randomized, Open-Label Study of a Nucleoside Analogue Reverse Transcriptase Inhibitor-Sparing Regimen in Antiretroviral-Naive HIV-Infected Patients
    Harris, Marianne
    Cote, Helene
    Ochoa, Claudia
    Allavena, Clotilde
    Negredo, Eugenia
    Thorne, Anona
    Cahn, Pedro
    Zala, Carlos
    Raffi, Francois
    Clotet, Bonaventura
    Singer, Joel
    Montaner, Julio
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (03) : 335 - 337
  • [5] Adherence to antiretroviral treatments with a protease inhibitor in HIV-infected patients
    Salmon-Céron, D
    Deleuze, J
    Coste, J
    Guerin, C
    Ginsburg, C
    Blanche, P
    Finkielsztejn, L
    Pecqueux, L
    Chaput, S
    Gorin, I
    Sicard, D
    ANNALES DE MEDECINE INTERNE, 2000, 151 (04): : 297 - 302
  • [6] Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults
    Young, B
    Fischl, MA
    Wilson, HM
    Finn, TS
    Jensen, EH
    DiNubile, MJ
    Zeldin, RK
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (05) : 478 - 482
  • [7] Protease inhibitor resistance in HIV-infected patients: Molecular and clinical perspectives
    Martinez-Cajas, Jorge L.
    Wainberg, Mark A.
    ANTIVIRAL RESEARCH, 2007, 76 (03) : 203 - 221
  • [8] Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy
    Dios, PD
    Ocampo, A
    Miralles, C
    Otero, I
    Iglesias, I
    Rayo, N
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1999, 87 (04): : 437 - 441
  • [9] Weight gain associated with protease inhibitor therapy in HIV-infected patients
    Stricker, RB
    Goldberg, B
    RESEARCH IN VIROLOGY, 1998, 149 (02): : 123 - 126
  • [10] Impact of protease inhibitor substitution with efavirenz in HIV-infected children: Results of the first pediatric switch study
    McComsey, G
    Bhumbra, N
    Rathore, M
    Alvarez, A
    PEDIATRICS, 2003, 111 (03)
12345